User Name Password

back to homepage

London Capital (LCG.L) - finals: spreading the good news
LCG.L
Comment by Objective Capital , Feb 20, 2008
Questions? Contact our analyst

LCG has announced preliminary results for the year ended 31 December 2007. Highlights were.:

  • turnover £19.98m (£8.65m) +119%;
  • EBITDA ££9.61m (£4.03m) +138%;
  • PBT (pre share option reserve) £9.31m (£3.91m) +138%;
  • net cash £10.28m (£3.35m);
  • final dividend 5.25p making a FY dividend of 6.50p per share (1.7p);
  • spread betting client funds on deposit £16.79m (£7.43m);
  • foreign exchange client funds on deposit £19.03m (£7.38m);

Objective's view:

These are stellar results, ahead of market expectations and proof that LCG’s business model thrives in volatile and turbulent markets. Aside from the headline figures which obviously show growth at the top end or ahead of market expectations there are other encouraging trends. Client funds on deposit have more than doubled, adding to the earnings capability (interest receivable) of the group.

During the year LCG signed up a number of white label partners for the spread betting product, the most prominent being Paddy Power and Betfair. These two partners are boosting new client acquisitions by about 500 a month between them, although no individual partner contributes more than 15% of revenue and white label in total contributes just under 30%. The white label contribution diversifies the client base, since these tend to be from a betting background rather than a financial markets background and they favour the more volatile indices and currencies rather than equities.

Client acquisition costs, confined to spread betting, continue to fall: the average in 2007 was £81 per client, down from £88 in 2006. We note that these figures are struck before the impact of white label acquisitions: their effect is to reduce the client acquisition cost yet further.

Foreign exchange continued to experience quarter-on-quarter profit growth and continues to see increasing numbers of trades. This business experienced very strong trading in the second and third quarters of 2007, clearly benefiting from unrest in financial markets following the sub-prime crisis. We do not expect any abrupt cessation to recent volatility trends.

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer